Performance of the GenoType® MTBDRPlus assay in routine settings: A multicenter study

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 7, 2012, Pages 1381-1387

  Mironova, S ^a   Pimkina, E ^b   Kontsevaya, I ^a   Nikolayevskyy, V ^c   Balabanova, Y ^c   Skenders, G ^d   Kummik, T ^e   Drobniewski, F ^c  

^a Samara Oblast TB Service   (Russian Federation)

^b University Hospital   (Lithuania)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^d State Agency Infectology Center of Latvia   (Latvia)

^e TARTU UNIVERSITY HOSPITAL   (Estonia)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN;

ACID FAST BACTERIUM; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COUNT; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; DIAGNOSTIC VALUE; MULTICENTER STUDY; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; RELIABILITY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SPUTUM SMEAR; STATISTICAL SIGNIFICANCE; USSR; CLINICAL TRIAL; DRUG EFFECT; EASTERN EUROPE; EVALUATION; GENETICS; GENOTYPE; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MOLECULAR DIAGNOSIS;

BACTERIOLOGICAL TECHNIQUES; EUROPE, EASTERN; GENOTYPE; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; MYCOBACTERIUM TUBERCULOSIS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84865608766     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-011-1453-1     Document Type: Article

References (32)

1. Raviglione MC, Smith IM (2007) XDR tuberculosis -implications for global public health. N Engl J Med 356(7):656-659
2. Leimane V, Dravniece G, Riekstina V, Sture I, Kammerer S, Chen MP, Skenders G, Holtz TH (2010) Treatment outcome of multidrug/extensively drug-resistant tuberculosis in Latvia, 2000-2004. Eur Respir J 36(3):584-593
3. Hillemann D, Rusch-Gerdes S, Richter E (2007) Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol 45(8):2635-2640
4. Huyen MN, Tiemersma EW, Lan NT, Cobelens FG, Dung NH, Sy DN, Buu TN, Kremer K, Hang PT, Caws M, O'Brien R, van Soolingen D (2010) Validation of the GenoType MTBDRplus assay for diagnosis of multidrug resistant tuberculosis in South Vietnam. BMC Infect Dis 10:149
5. Migliori GB, Sotgiu G, Lange C, Centis R (2010) Extensively drug-resistant tuberculosis: Back to the future. Eur Respir J 36 :475-477
6. WHO (2008) Anti-tuberculosis drug resistance in the world. Fourth global report. WHO/HTM/TB/2008.394. World Health Organization, Geneva, Switzerland
7. Palomino JC (2005) Nonconventional and new methods in the diagnosis of tuberculosis: Feasibility and applicability in the field. Eur Respir J 26(2):339-350
8. Hillemann D, Rusch-Gerdes S, Richter E (2009) Feasibility of the GenoType MTBDRsl assay for fluoroquinolone, amikacincapreomycin, and ethambutol resistance testing of Mycobacterium tuberculosis strains and clinical specimens. J Clin Microbiol 47 (6):1767-1772
9. Abebe G, Paasch F, Apers L, Rigouts L, Colebunders R (2010) Tuberculosis drug resistance testing by molecular methods: Opportunities and challenges in resource limited settings. J Microbiol Methods 84(2):155-160
10. Albert H, Bwanga F, Mukkada S, Nyesiga B, Ademun JP, Lukyamuzi G, Haile M, Hoffner S, Joloba M, O'Brien R (2010) Rapid screening of MDR-TB using molecular line probe assay is feasible in Uganda. BMC Infect Dis 10:41
11. Ahmad S, Al-Mutairi NM, Mokaddas E (2009) Comparison of performance of two DNA line probe assays for rapid detection of multidrug-resistant isolates of Mycobacterium tuberculosis. Indian J Exp Biol 47(6):454-462
12. Shah NS, Lan NT, Huyen MN, Laserson K, Iademarco MF, Binkin N, Wells C, Varma JK (2009) Validation of the line-probe assay for rapid detection of rifampicin-resistant Mycobacterium tuberculosis in Vietnam. Int J Tuberc Lung Dis 13(2):247-252
13. WHO (2008) Molecular line probe assays for rapid screening of patients at risk of multidrug resistant tuberculosis (MDR-TB). Policy Statement World Health Organization, Geneva, Switzerland
14. Evans J, Stead MC, Nicol MP, Segal H (2009) Rapid genotypic assays to identify drug-resistant Mycobacterium tuberculosis in South Africa. J Antimicrob Chemother 63(1):11-16
15. Bwanga F, Hoffner S, Haile M, Joloba ML (2009) Direct susceptibility testing for multi drug resistant tuberculosis: A meta-analysis. BMC Infect Dis 9:67
16. Barnard M, Albert H, Coetzee G, O'Brien R, Bosman ME (2008) Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am J Respir Crit Care Med 177(7):787-792
17. Bazira J, Asiimwe BB, Joloba ML, Bwanga F, Matee MI (2010) Use of the GenoType(R) MTBDRplus assay to assess drug resistance of Mycobacterium tuberculosis isolates from patients in rural Uganda. BMC Clin Pathol 10:5
18. Mokrousov I, Jiao WW, Sun GZ, Liu JW, Valcheva V, Li M, Narvskaya O, Shen AD (2006) Evolution of drug resistance in different sublineages of Mycobacterium tuberculosis Beijing genotype. Antimicrob Agents Chemother 50(8):2820-2823
19. Rodrigues C, Shenai S, Sadani M, Sukhadia N, Jani M, Ajbani K, Sodha A, Mehta A (2009) Evaluation of the bactec MGIT 960 TB system for recovery and identification of Mycobacterium tuberculosis complex in a high through put tertiary care centre. Indian J Med Microbiol 27(3):217-221
20. Lee JJ, Suo J, Lin CB, Wang JD, Lin TY, Tsai YC (2003) Comparative evaluation of the BACTEC MGIT 960 system with solid medium for isolation of mycobacteria. Int J Tuberc Lung Dis 7(6):569-574
21. WHO (2011) World Health Organization towards universal access to diagnosis and treatment of multidrug-resistant and extensively drug-resistant tuberculosis by 2015. WHO progress report, 23 March 2011. Report no.: WHO/HTM/TB/2011.3
22. Ling DI, Zwerling AA, Pai M (2008) GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: A metaanalysis. Eur Respir J 32(5):1165-1174
23. Balabanova Y, Drobniewski F, Nikolayevskyy V, Kruuner A, Malomanova N, Simak T, Ilyina N, Zakharova S, Lebedeva N, Alexander HL, O'Brien R, Sohn H, Shakhmistova A, Fedorin I (2009) An integrated approach to rapid diagnosis of tuberculosis and multidrug resistance using liquid culture and molecular methods in Russia. PLoS One 4(9):e7129
24. Nikolayevskyy V, Balabanova Y, Simak T, Malomanova N, Fedorin I, Drobniewski F (2009) Performance of the Genotype MTBDRPlus assay in the diagnosis of tuberculosis and drug resistance in Samara Russian Federation. BMC Clin Pathol 9:2
25. Miotto P, Saleri N, Dembele M, Ouedraogo M, Badoum G, Pinsi G, Migliori GB, Matteelli A, Cirillo DM (2009) Molecular detection of rifampin and isoniazid resistance to guide chronic TB patient management in Burkina Faso. BMC Infect Dis 9:142
26. Anek-Vorapong R, Sinthuwattanawibool C, Podewils LJ, McCarthy K, Ngamlert K, Promsarin B, Varma JK (2010) Validation of the GenoType MTBDRplus assay for detection of MDR-TB in a public health laboratory in Thailand. BMC Infect Dis 10:123
27. Skenders G, Fry AM, Prokopovica I, Greckoseja S, Broka L, Metchock B, Holtz TH, Wells CD, Leimane V (2005) Multidrugresistant tuberculosis detection, Latvia. Emerg Infect Dis 11 (9):1461-1463
28. Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, Tahirli R, Gler MT, Blakemore R, Worodria W, Gray C, Huang L, Caceres T, Mehdiyev R, Raymond L, Whitelaw A, Sagadevan K, Alexander H, Albert H, Cobelens F, Cox H, Alland D, Perkins MD (2011) Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: A multicentre implementation study. Lancet 377(9776):1495-1505
29. Ioannidis P, Papaventsis D, Karabela S, Nikolaou S, Panagi M, Raftopoulou E, Konstantinidou E, Marinou I, Kanavaki S (2011) Cepheid GeneXpert MTB/RIF assay for Mycobacterium tuberculosis detection and rifampin resistance identification in patients with substantial clinical indications of tuberculosis and smearnegative microscopy results. J Clin Micobiol 49(8):3068-3070
30. Rinder H, Mieskes KT, Loscher T (2001) Heteroresistance in Mycobacterium tuberculosis. Int J Tuberc Lung Dis 5(4):339-345
31. Baldeviano-Vidalon GC, Quispe-Torres N, Bonilla-Asalde C, Gastiaburu-Rodriguez D, Pro-Cuba JE, Llanos-Zavalaga F (2005) Multiple infection with resistant and sensitive M. tuberculosis strains during treatment of pulmonary tuberculosis patients. Int J Tuberc Lung Dis 9(10):1155-1160
32. Hofmann-Thiel S, van Ingen J, Feldmann K, Turaev L, Uzakova GT, Murmusaeva G, van Soolingen D, Hoffmann H (2009) Mechanisms of heteroresistance to isoniazid and rifampin of Mycobacterium tuberculosis in Tashkent, Uzbekistan. Eur Respir J 33(2):368-374